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Abstract 
 
Vasomotor symptoms (VMS) associated with menopause vary greatly, as do the multitude of 
available treatment options. It can be difficult for clinicians to manage these symptoms while 
balancing patient safety concerns and preferences. Shared decision-making (SDM) can assist 
both the provider and patient to navigate the various treatment options, minimizing gaps between 
their preferences. To assess the effect of SDM in a nurse-led practice in the Southwest, two nurse 
practitioners (NP) were invited to use a menopausal decision aid (DA). Women aged 40 to 64 
years experiencing VMS were invited to participate in the project. Following a visit with the NP 
in which the DA was used, patients completed a six question post-intervention survey based on 
both the Decisional Conflict Scale (DCS) and SDM-Q-9 surveys. Patients were also asked to 
complete a telephone interview about the process 1-2 weeks post-intervention. The NP completed 
a post-intervention survey based on the SDM-Q-Doc to assess clinician satisfaction with the SDM 
process. Eight patients (mean age, 47.9 years), presenting with a range of 2 to 6 perimenopausal 
symptoms participated in the project. All patients (100%) strongly or completely agreed that the 
clinician precisely explained the advantages & disadvantages of treatment options, helped them 
understand all the information, reached an agreement on how to proceed with care, and were 
extremely satisfied or satisfied with their decision and making an informed choice. Both 
clinicians completely agreed they had come to an agreement on how to proceed, and completely 
or strongly agreed they helped the patient understand all information. There was a correlation 
between the use of SDM patient’s age, making an informed choice, and being satisfied with their 
decision.  Incorporating a perimenopausal DA can enhance patient and clinician satisfaction with 
SDM to understand their treatment options and make an informed menopausal decision. 
 Keywords:  menopause, shared decision making, decision aid, vasomotor symptoms 
 Running head:  SHARED DECISION MAKING                                                                       3 
 
 
Increasing perimenopausal patient and clinician satisfaction with SDM 
 For many women experiencing menopause, the symptoms can be a source of confusion 
and frustration. According to the North American Menopause Society [(NAMS), 2015], more than 
seventy-five percent of women in midlife experience vasomotor symptoms associated with 
menopause.  These symptoms last approximately five to seven years; however, they can continue 
for longer than fifteen years. Symptoms vary widely in terms of frequency, intensity, and the type 
of symptoms.  For each symptom there are a number of treatment options available. Therefore, 
selection from among the myriad of choices for treatment can be difficult for practitioners and 
patients alike. Of 293 women surveyed on VMS treatment options alone, nearly half reported 
feeling confused (NAMS, 2015).  In order to help streamline these patient encounters, a shared 
decision making (SDM) tool can be invaluable. SDM is an approach in which patients and 
clinicians together utilize an evidence-based tool to facilitate informed patient choices and include 
patient preferences on how to proceed with their care (Elwyn et al., 2012). 
Background and Significance 
Midlife Women with Menopausal Symptoms 
An estimated 38 million women between ages 45 to 64 years’ experience VMS daily in the 
U.S. (Reed et al., 2014). The two most commonly reported menopausal symptoms - a sudden 
sensation of mild or intense body heat (“hot flashes”) and diaphoresis during sleep (“night sweats”) 
- occur in approximately 75% of women (NAMS, 2015; NAMS, 2016). These symptoms can 
contribute to mood and sleep disturbances, diminished energy, vaginal dryness, low-libido, and 
concentration difficulties, disrupting a woman’s quality of life (Reed et al., 2014). If untreated, the 
economic and healthcare burden of VMS is significant. One retrospective cohort study of 
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500,000 women’s insurance claims demonstrated that women with VMS incurred over 1.5 
million VMS-related outpatient visits over a one year span, totaling over $339 million in direct 
costs, and $27.6 million in indirect costs such as lost work days (Sarrel et al., 2015). Another 
study found the higher the VMS symptom severity, the greater work productivity loss, healthcare 
usage, and overall poorer health status than for those females with mild or no symptoms 
(Whiteley et al., 2013).  
Shared Decision Making 
VMS vary dramatically, as do the variety of treatment options available. In order to help 
streamline these patient encounters, a SDM tool, or decision aid (DA), can be utilized to enhance 
decision making, giving the patients options to make informed  choices  and express their 
preferences on how to proceed with their care (Elwyn et al., 2012). SDM tools are endorsed by the 
American College of Obstetricians and Gynecologists (ACOG), National Cancer Institute and U.S. 
Institute of Medicine, and can be effective in reducing patient misperceptions of symptoms and 
minimizing gaps between the clinician and patient communication (ACOG, 2014; Brown et al., 
2012; Kiatpongsan, Carlson, Feibelmann, & Sepucha, 2014). Conceptualized in the 1990’s by 
Charles et al., (1997) the SDM model is an interactional process between the patient and 
clinician, developed to equip the patient with information, and empower participation in the 
treatment decision-making process (Brown et al., 2012).  
By encouraging practitioners to incorporate and focus on the patient and their specific 
preferences versus strictly on disease management, SDM is strategy for enhancing patient-
centered healthcare. In a recent Cochrane review, when comparing decision aids to usual care (or 
non-decision aids), exposure to a decision aid resulted in increased patient knowledge and a higher 
percentage of patients electing a treatment option congruent with their personal values.  The same 
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systematic review confirmed that decision aids had a positive effect on practitioner-patient 
communication and patient satisfaction with the selected decision and decision-making process 
(Stacey et al., 2014).  The goal of the project was to provide clinicians with a better understanding 
of SDM use in the clinical setting for improved VMS management, enhanced clinician self-
efficacy, and patient empowerment.  
Search Strategy 
The inquiries led to the clinically relevant PICOT question, “In midlife women 
experiencing menopausal symptoms, how does implementing a shared decision making (SDM) 
tool for menopausal symptom management compare to current practice or no-SDM tool in the 
impact on patient satisfaction with decision, decisional conflict, and clinician satisfaction?”  
Database Search 
 An extensive search was conducted on the following three databases to answer the PICO 
question:  Cochrane Database of Systematic Reviews, PubMed Central (PMC), and Cumulative 
Index to Nursing and Allied Health Literature (CINAHL). These databases were selected for 
their relevance in medical, nursing, and psychological content. Initial search terms included the 
following medical subject heading (MeSH) terms in alignment with Boolean connectors:  shared 
decision making (and) women (or) decision aid(s) (AND) women (or) vasomotor symptoms (and) 
shared decision making. Limitations placed on these terms included primary research articles, 
publication timeframe, and publication language. Initial abstract yields were analyzed utilizing 
the PRISMA Flowchart inclusion and exclusion criteria in order to determine relevance to PICO 
question.  
Inclusion and Exclusion Criteria 
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 Inclusion criteria included peer-reviewed articles, and clinical trials published in English 
between 2011 and 2016. Additionally, articles that reported the outcomes of the use of shared 
decision making or a decision aid with a complex health decision, and had females as the 
primary participants were selected. Studies were excluded if they did not meet inclusion criteria 
or were not sufficiently relevant. 
Initial and Final Yields  
 The Cochrane Database of Systematic Reviews yielded 13 results from 9,236 records 
utilizing the MeSH term SDM. Next, the initial PMC search generated 86 results from 1941 
articles on SDM utilizing the following MeSH terms:  menopausal symptoms, menopause, 
hormone replacement, menopause symptoms, SDM, decision making, DA, informed decisions, 
satisfaction, or preference. Lastly, the CINAHL database yielded 28 results with MeSH terms:  
DA, SDM, informed decision, hormone replacement, or hormone. Collectively, the three 
databases generated 127 journal articles related to SDM. These articles were further scrutinized 
for relevance to the selected PICOT question, and a final yield of 37 journal articles were 
examined using rapid critical appraisal (Melnyk, 2015). Of these, 11 articles were selected for 
inclusion in this review.   
Critical Appraisal and Synthesis of Evidence 
 The eleven studies consulted in this review of SDM for menopausal symptom 
management, included eight randomized controlled trials, two qualitative reviews, and one 
retrospective survey. The studies primarily demonstrated high to moderately high quality and 
strength, including three systematic reviews (level I evidence), four randomized RCTs (level II 
evidence), and two non-randomized RCTs (level III evidence) based on Melnyk and Fineout-
Overholt (2011) revised Hierarchy of Evidence Rating System. Additionally, the majority of 
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studies reported the level of significance (p value) and confidence intervals, and data analysis for 
all studies had appropriately selected tests to evaluate study design and methodology. Studies 
incorporated the use of Fischer’s exact test, t-test for comparing continuous variables, the x2 test 
for categorical values, the Linear mixed effects model, and the Logistic Regression Model 
enhancing the validity and reliability. 
 A moderate amount of homogeneity was demonstrated among the sample. Of studies 
incorporating race, the majority of participants identified as Caucasian (48-74%), and the average 
age of participants ranged from 51 to 63.1 years, with all but one study primarily including female 
participants (54.5%-100%) [Leighl et al., 2011]. A DA was the primary intervention utilized within 
all studies, and varied based on the intended intervention and patient population. Although only 
two studies were directly focused on the use of SDM and MSM, all studies involved using SDM or 
decision aids for making a complex health decision, thereby making it relevant to the PICOT 
question. Therefore, evidence suggests that use of SDM to guide discussions about management 
options for complex menopausal symptoms is an effective strategy.   
Purpose Statement 
Navigating the complex variety of menopausal treatment options to incorporate the 
patient’s individual attitude and values, with external factors such as risks versus benefits, can be 
challenging for practitioners. Achieving this delicate balance of patient preference with available, 
evidence based treatment modalities can be achieved through a SDM process (Carpenter, Byrne, & 
Studts, 2011). This project aims to determine if, when a standardized DA is introduced in a private 
practice setting, patient decisional conflict will decrease, and patient satisfaction with decision and 
clinician satisfaction will increase.   
Evidence-Based Practice Model and Conceptual Framework 
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 In order to implement the use of a DA at the project site, the Rosswurm and Larrabee’s 
Model for EBP change was utilized to design and plan the introduction of the proposed practice 
change in a logical sequence. Rosswurm and Larrabee’s Model consists of six steps:  assess, link, 
synthesize, design, implement and evaluate, and integrate and maintain (Rosswurm & Larrabee, 
1999). After assessing clinic menopausal symptom discussions with patients, it was determined 
that the care was not standardized. Initial internal data collection identified 423 females that were 
seen in the previous year for menopausal symptoms. The project manager presented evidence to 
the clinicians that approaching menopausal management with a proven intervention could result in 
increased patient and provider satisfaction with the care encounter. In collaboration with the NP 
and staff, a plan was designed on how the use of the algorithm and shared decision-making 
approach would be implemented and evaluated. By including the NPs and staff in the planning and 
execution of the plan, the foundation was set for the behavior to become a routine practice and 
maintained, assuming that the SDM was found to be a good fit for this practice. The Menopro 
algorithm is a validated tool endorsed by NAMS (2015) designed to assist clinicians and patients to 
determine appropriate menopausal treatment options.  
 Incorporating patient preferences into patient centered care actions through utilization of a 
DA is in alignment with the Collaborative Deliberation Theoretical Model (Elwyn et al., 2014). 
This model is grounded in integrating an empathetic and respectful approach to interactive 
communication and deliberation, and is composed of five constructs:  constructive engagement, 
recognition of alternative actions, comparative learning, preference construction and elicitation, 
and preference integration (Elwyn et al., 2014). Constructive engagement included the use of an 
approach that actively involved the patient and practitioner exploring solutions to a health problem 
that was of concern to the patient. Recognition of alternative actions occurred when patients were 
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able to recognize relevant alternative actions, which may or may not be beneficial to 
perimenopausal symptom management. Comparative learning occurred when the clinician was 
able to utilize the decision aid to facilitate and transmit available treatment options, and in turn the 
patient utilizes this information to be able to make a decision on treatment options. Preference 
construction and elicitation incorporates the patient’s preferences, values, and motivation. 
Preference integration occurred when the patient’s expressed preferences were included in the 
clinician’s management plan. Collaborative deliberation, participants can effectively utilize a DA 
to review relevant risks and benefits of potential treatment options.  
Methods 
Study Design 
Two clinicians in a small, private practice in the Southwest were recruited to participate 
in a project to introduce the use of a menopausal algorithm (decision aid) to enhance 
perimenopausal symptom management over a 2-month timeframe. Arizona State University 
Institutional Review Board assigned an expedited approval for the protocol. Current practice did 
not include shared decision-making or decision aids. The single-page menopausal algorithm was 
based on the NAMS Menopro app and Australian Menopause Society menopause algorithms. 
Permission to utilize both applications were obtained prior to study initiation. Practitioners 
received a 30-minute training on use of the menopausal algorithm in practice to guide the SDM 
patient communication to discuss evidence-based approaches to manage VMS and the risks and 
benefits of each option.   
 Eligible patients were invited to participate when they presented to the clinic if they were 
English-speaking, female patients aged 40 to 64 years who presented with perimenopausal 
symptoms, as reflected by their responses to a Menopausal Rating Scale (MRS) received at 
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appointment check-in, which is current protocol at practice site. The MRS is reviewed by the 
practitioner prior to entering the room. If the MRS indicated that the patient was experiencing 
menopausal symptoms or concerns, the NP provided the patient with a project information and 
invitation letter and obtained informed consent. Additionally, patients received an ACOG patient 
education hormone therapy fact sheet for review prior to appointment. A single page post-
intervention survey was administered to patients following the visit which included a section for 
patients to indicate their present health concern, treatment decision (hormone therapy, lifestyle 
choice, or alternative), and six quantitative questions based on both the Decisional Conflict Scale 
(DCS) and SDM-Q-9 surveys. Three questions from the Decisional Conflict Scale (DCS) were 
used to measure patient decisional conflict following the SDM intervention.:  this validated, 16-
item questionnaire is a 5-point Likert scale scored from 1 (extremely dissatisfied) to 5 (extremely 
satisfied), with initial psychometric testing of DCS found an internal consistency (α = 0.78 to 
0.92), and reliability coefficient 0.81, (O’Connor, 1995). Subsequent studies found internal 
consistency (α = 0.63 to 0.97) [Katapodi, Munro, Pierce, & Williams, 2011]. Three questions from 
the SDM-Q-9 survey were utilized to measure patient’s satisfaction with menopausal decisions 
made with a SDM intervention:  this validated, 9-item questionnaire is a 6-point Likert scale scored 
from 1 (completely disagree) to 6 (completely agree), with lower values representing more 
conflict. Initial psychometric testing of SDM-Q-9 found a high reliability, internal consistency (α > 
0.9) [Kriston et al., 2010].  
 After each patient visit, the practitioners answered three questions from the Shared 
Decision Making Questionnaire Physician Version (SDM-Q-Doc). The SDM-Q-Doc assessed the 
clinician’s perspective and satisfaction with the SDM process in menopausal management (Scholl, 
Kriston, Dirmaier, Buchholz, & Harter, 2012). This validated, 9-item questionnaire is a 6-point 
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Likert scale scored from one (1) (completely disagree) to six (6) (completely agree), and is 
available free online. Initial psychometric SDM-Q-Doc testing found an interval consistency (α = 
0.88), and received a high level of acceptance from participating physicians during instrument 
assessment. Inter-item correlation scores ranged from 0.131 to 0.744 (M = 0.443), demonstrating a 
moderate reliability for clinician SDM assessment (Scholl et al., 2012). Women’s Health NPs with 
experience in caring for perimenopausal women were utilized to validate all modified instruments 
used in the project for validity and reliability.  
 A telephone call was made to patients to complete an interview to evaluate if:  (1) the 
patient was able to follow the prescribed plan of care, (2) patient was satisfied with her choices, 
and (3) there were any additional questions or concerns. The interview questions were designed by 
the practice owner, and reviewed by project manager and expert reviewers for validity.  
Intervention 
 If patients agreed to participate in the project, the clinician utilized the SDM menopausal 
algorithm to discuss patient concerns, available evidenced based approaches to managing their 
symptoms, the risks and benefits for each options, and to guide the discussion to determine an 
agreeable plan of care for both patient and practitioner. At the visit’s conclusion, patients were 
invited to complete the modified DCS and SDM-Q-9. The NP completed the modified SDM-Q-
Doc at the conclusion of the visits. One to two weeks after the patient’s appointment, study 
personnel called the patient for the follow-up survey  
Data Analysis 
 A Spearman rho correlation coefficient was calculated to examine the relationship between 
a participant’s age and SDM questionnaires, and the relationship between the practitioner’s clinical 
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management decision and the SDM-Q-Doc. All statistical analysis were performed utilizing SPSS 
23. 
Results 
Patient Shared Decision Making Process  
Eight female patients completed surveys (72% participation rate). The mean age of the 
patients was 47.9 years (range 40-53). Patients presented with a mean average of 3 (range 2-6) 
perimenopausal symptoms, as noted on the MRS (Table 1). Seventy-five percent (6) of patients 
noted low-libido, 62.5% (5) hot flashes, and 37.5% (3) night sweats. The remainder of symptoms 
included (1) insomnia, (3) fatigue (mental or physical), (1) joint pain, (1) joint discomfort, (1) heart 
discomfort, (1) sleep problems, and (1) irritability. Additionally, on the post-intervention survey, 
all patients noted they had menopausal or hormonal symptoms concerns, and 87.5% of patients (in 
conjunction with their practitioner), selected hormone therapy as treatment of choice, the other 
participant did not note a treatment selection. 
Table 1.  Clinical concerns on Menopause Rating 
Scale 
Clinical Concerns  n (%) 
Low libido 6 (75) 
Hot flashes 5 (62.5) 
Night sweats 3 (37.5) 
Fatigue (mental &/or physical) 3 (37.5) 
Insomnia 1 (12.5) 
Joint discomfort 1 (12.5) 
Joint pain 1 (12.5) 
Heart discomfort 1 (12.5) 
Sleep problems 1 (12.5) 
Irritability 1 (12.5) 
 
  The majority of patients (87.5%) completely agreed the practitioner precisely explained 
the advantages & disadvantages of treatment options, helped them understand all the 
information, and reached an agreement on how to proceed with care. Seventy-five percent were 
extremely satisfied with their decision and making an informed choice. Clinicians completely 
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agreed they had come to an agreement on how to proceed, and 87.5% completely agreed they 
helped the patient understand all the information. A positive correlation was found (rho (8)=.026, 
p<.001), indicating a significant relationship between age and participant’s “I am satisfied with my 
decision” and “I feel I have made an informed choice”. The remainder of the survey results were 
not normally distributed or significant (Table 2).  
 Three (37.5%) of participants were able to be contacted for the post-intervention telephone 
interview. Results revealed all patients were satisfied with their treatment choices (all selected 
hormone therapy), and have been able to follow the mutually agreed upon plan of care. One patient 
noted she “had an idea going in on what she wanted, but she did go over pros and cons for each 
choice, and it was informative. Although I went with my initial choice, it was nice to hear all the 
options”. Another participant stated “(she) did not know anything about all the hormonal options 
so (she) was very happy to learn about available treatment options so (she) doesn’t have to worry 
about mush on the brain (mental fatigue).” The third participant noted “(she) was very happy with 
the overall experience, and was doing (her own) research as well, and feels very secure with (her) 
comfort level and decision to utilize hormone therapy and will be transferring all (her) future care 
over to the NPs practice”. No patients had any additional questions or concerns regarding their 
care. 
  
Table 2.  Patient surveys              
SDM-Q-9 
Mean 
(SD) 
Completely    
agree                   
f (%) 
Strongly    
agree              
f (%)  
My practitioner precisely explained the advantages and disadvantages of the treatment options 
5.88 
(.354) 7 (87.5) 1 (12.5)  
My practitioner helped me understand all the information 
5.88 
(.354) 7 (87.5) 1 (12.5)  
My practitioner and I reached an agreement on how to proceed 
5.88 
(.354) 7 (87.5) 1 (12.5)  
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DCS 
Mean 
(SD) 
Extremely 
satisfied               
f (%)  
Very    
satisfied          
f (%) 
Satisfied                 
f (%) 
I feel I have made an informed choice 
4.63 
(.744) 6 (54.5) 1 (12.5) 1 (12.5) 
I am satisfied with my decision 
4.63 
(.744) 6 (54.5) 1 (12.5) 1 (12.5) 
Overall medical care at your doctor's office 
5.00 
(.000) 8 (100)     
 
Practitioners Shared Decision Making Process  
 Two practitioners completed the SDM-Q-Doc patient surveys after patient encounters. 
Both clinicians utilized the perimenopausal algorithm, although one used it more than the other due 
to appointment availability, and one SDM-Q-Doc survey was not conducted post-clinical visit. 
Both responded to the questions in ways that indicated that they found that the tool enabled them to 
engage the patient in the collaborative discussion and treatment decision. They believed the 
discussion helped the patient to understand all the information provided, and they agreed that they 
covered all the benefits and disadvantages of the options. There was a difference between provider 
and patient preferences, but the patient preference was the one selected for the management plan.  
Discussion 
 The majority of patient respondents strongly favored using SDM in order to better 
understand perimenopausal symptom treatment options, and make an informed and satisfying 
choice. Overall, patients were satisfied with the care received during the SDM visit to address their 
varying perimenopausal symptoms. In fact, on one of the practitioner’s hand-written surveys, it 
was noted that the patient found the information very helpful. The potential benefits of using SDM 
in practice from a patient perspective demonstrated that a patient’s age correlated with a 
practitioner’s ability to help them understand perimenopausal treatment options provided and reach 
agreement on how to proceed with care in congruence with patient choices. So, for instance, the 
older the patient, the more likely the patient would report the algorithm helped them to understand 
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the options and reach an agreement on the treatment plan. Furthermore, SDM enhanced patient 
satisfaction with their decision and making an informed choice.  
 From a practitioner perspective, the project demonstrated that practitioners at least strongly 
agreed they were able to explain the advantages and disadvantages of menopausal treatment 
options, helping the patient to understand all of the information provided, and in turn, come to a 
joint agreement with treatment plans in all SDM visits. Although the patient results were favorable, 
feedback received from one of the practitioners was not as favorable, related to the amount of 
information the patients were given to review, and the limited treatment selection choices based on 
the NAMS algorithm and patient education handouts.   
 It may be beneficial to have a shorter patient education handout for patients to review prior 
to clinic appointment. The ACOG hormone therapy patient education fact sheet was selected for 
use based on its thorough descriptions of the various treatment options including risks, benefits, 
and side effects (ACOG, 2015). However, due to 5-page length, the practitioner expressed 
concerns over patients not having time to read the information, or lack of willingness of patients to 
read educational materials. Furthermore, by some patients receiving information directly prior to 
appointment, it caused a slight delay in appointment start time. Some recommendations for future 
educational materials would be to provide patients education materials to read in a timely manner 
by distributing via electronically through practice patient portal or make educational pamphlets 
tailored to patients’ specific inquiries or symptom concerns if applicable.  
Project Limitations 
 Although this project included a small number of patients and only two practitioners, it 
demonstrated that SDM in practice may be beneficial for the patient when reviewing pros and cons 
of viable treatment options when making a complex health care decision. Furthermore, there was 
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no pre-intervention data collected, thereby, an analysis could not be conducted to determine if 
utilizing the SDM algorithm was more beneficial than not utilizing one, as was previous practice. 
Additionally, some of the practitioner treatment selections were not listed on the algorithm, 
resulting in the practitioner needing to verbalize preferred treatment options, data that may or may 
not be incorporated into the data analysis. These treatment selections were not included on the 
NAMS algorithm; therefore it was not included in the SDM tool for project purposes, and resulted 
in some dissatisfaction with the tool on the part of the practitioner. However, for future practice, 
the algorithm could be tailored based on specific practitioner requirements.  
Conclusion 
This project aimed to enhance clinician and patient satisfaction with health care encounters 
for discussions about perimenopausal symptom management. By providing clinicians with a SDM 
guide to facilitate discussion of risks, benefits, and treatment options for VMS symptoms, this 
collaborative care approach enhanced the clinician and patients’ healthcare experience through an 
interactional process of patient empowerment. This project correlated with current research 
demonstrating SDM is valuable in practice to enhance patient satisfaction, understanding, and 
knowledge while reducing decisional conflict when choosing a perimenopausal treatment plan. All 
patient and clinician responses were positive in nature, and identified that SDM is valuable in 
practice.  
Recommendations for future projects or related research should include providing patient 
education handouts tailored to patients primary symptom concerns, given in an advanced 
timeframe as to not interrupt or delay patient care timeliness. Furthermore, lengthening project 
timeframe could incorporate more females with VMS symptoms, further solidifying project 
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effectiveness. Additionally, the algorithm could be tailored incorporate clinician preferences to 
enhance communication by incorporating all alternative treatment modalities.  
Implications for future practice are exponential in nature for supporting patient centered 
care and the Centers for Medicare and Medicaid qualitative initiatives. Undertaking this simplistic 
system change can be easily sustainable in practice, and can be beneficial to inexperienced or 
seasoned clinicians alike. Most importantly, assisting women with perimenopausal concerns 
through a proven evidenced based intervention such as SDM will undoubtedly enhance their 
satisfaction and quality of life, thereby reducing decisional conflict and improving symptom 
concerns.  
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